News
Global Pharma Morale On A New High
Pharma confidence in growth, innovation, and process efficiency has reached record highs, according to the results of the CPhI's 2022 Pharma Index poll, which were released at this year's CPhI Frankfurt. This bodes well for the industry's prospects in...
News
Good Laboratory Practices: Why They’re Important and how to Implement Them
Good laboratory practices are important because they keep labs from misinterpreting their results and prevent contamination. As such, GLPs are especially important when dealing with living organisms or cells, which can spread disease and cause other forms of infection...
Drug Research
$2mn In The US, Gene Therapies Might Become The Standard
In recent years, the high cost of gene therapies has emerged as a major barrier to the development of personalised medicines. Most notably, bluebird Bio was forced to pull its blood disorder medicine Zynteglo from the European market after...
News
U.S. Cancer Medicine Pricing Increases 53% In Five Years
According to new research by Katie Porter, U.S. Democratic Representative and a consumer bankruptcy law professor vying for re-election in California, the cost of a newly-launched cancer medicine in the United States was $283,000 last year, a 53% rise...
Drug Research
The Reauthorization of The FDA User Fee Comes Into Effect
As anticipated, Congress swiftly reauthorized four important user fee programmes as part of a bill that was essential to passing in order to continue funding the federal government for another two months. The October 1 deadline for approving a...
Clinical Trials
Cancer Clinical Trials Begin On New Platform In Melbourne
By comparing tumour samples taken before and after treatment, a new clinical trial platform called Brain-POP (brain perioperative) will allow doctors to precisely see how a new medication therapy affects a patient's brain cancer.
The project, which the Brain Cancer...
News
UK R&D Worldwide Spending Share £62bn Short, Data Shows
According to a recent data study by the Institute for Public Policy Research, the UK's share of worldwide research and development (R&D) spending has decreased by 5% since 2014.
Despite exceeding the government's aim of 2.4% GDP for R&D expenditure,...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read